{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:58:57Z","timestamp":1787025537078,"version":"build-2736575974"},"reference-count":29,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,2,12]]},"published-print":{"date-parts":[[2026,6]]},"DOI":"10.2967\/jnumed.125.271605","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:20:13Z","timestamp":1772727613000},"page":"1001-1005","source":"Crossref","is-referenced-by-count":1,"title":["Validation of an AI Method for Automated Lymphoma Metabolic Tumor Volume Segmentation Using a Public Benchmark PET\/CT Dataset"],"prefix":"10.2967","volume":"67","author":[{"given":"May","family":"Sadik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mns","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Enqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edenbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Trgrdh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026060105301018000_67.6.1001.1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.annonc.2023.10.121","article-title":"Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial","volume":"35","author":"Cottereau","year":"2024","journal-title":"Ann Oncol."},{"key":"2026060105301018000_67.6.1001.2","first-page":"3055","article-title":"Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma","volume":"141","author":"Eertink","year":"2023","journal-title":"Blood."},{"key":"2026060105301018000_67.6.1001.3","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index","volume":"40","author":"Mikhaeel","year":"2022","journal-title":"J Clin Oncol."},{"key":"2026060105301018000_67.6.1001.4","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1182\/bloodadvances.2021006923","article-title":"A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma","volume":"6","author":"Thieblemont","year":"2022","journal-title":"Blood Adv."},{"key":"2026060105301018000_67.6.1001.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.019"},{"key":"2026060105301018000_67.6.1001.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795476"},{"key":"2026060105301018000_67.6.1001.7","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J Clin Oncol."},{"key":"2026060105301018000_67.6.1001.8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/JCO.21.01234","article-title":"Response-adapted postinduction strategy in patients with advanced-stage follicular lymphoma: the FOLL12 study","volume":"40","author":"Luminari","year":"2022","journal-title":"J Clin Oncol."},{"key":"2026060105301018000_67.6.1001.9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/joim.12813","article-title":"FDG-PET\/CT in the management of lymphomas: current status and future directions","volume":"284","author":"El-Galaly","year":"2018","journal-title":"J Intern Med."},{"key":"2026060105301018000_67.6.1001.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3315-7"},{"key":"2026060105301018000_67.6.1001.11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3303"},{"key":"2026060105301018000_67.6.1001.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269271"},{"key":"2026060105301018000_67.6.1001.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267183"},{"key":"2026060105301018000_67.6.1001.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238923"},{"key":"2026060105301018000_67.6.1001.15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2967\/jnumed.119.227249","article-title":"Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden","volume":"60","author":"Barrington","year":"2019","journal-title":"J Nucl Med."},{"key":"2026060105301018000_67.6.1001.16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","author":"Ilyas","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026060105301018000_67.6.1001.17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00259-018-4005-4","article-title":"Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?","volume":"45","author":"Cottereau","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026060105301018000_67.6.1001.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.180406"},{"key":"2026060105301018000_67.6.1001.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140830"},{"key":"2026060105301018000_67.6.1001.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267789"},{"key":"2026060105301018000_67.6.1001.21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cpf.12868","article-title":"Metabolic tumour volume in Hodgkin lymphomaa comparison between manual and AI-based analysis","volume":"44","author":"Sadik","year":"2024","journal-title":"Clin Physiol Funct Imaging."},{"key":"2026060105301018000_67.6.1001.22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13139-022-00765-3","article-title":"Artificial intelligence increases the agreement among physicians classifying focal skeleton\/bone marrow uptake in Hodgkins lymphoma patients staged with [18F]FDG PET\/CTa retrospective study","volume":"57","author":"Sadik","year":"2023","journal-title":"Nucl Med Mol Imaging."},{"key":"2026060105301018000_67.6.1001.23","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1038\/s41598-021-89656-9","article-title":"Artificial intelligence could alert for focal skeleton\/bone marrow uptake in Hodgkins lymphoma patients staged with FDG-PET\/CT","volume":"11","author":"Sadik","year":"2021","journal-title":"Sci Rep."},{"key":"2026060105301018000_67.6.1001.24","doi-asserted-by":"crossref","unstructured":"Gatidis S Kuestner T . A whole-body FDG-PET\/CT dataset with manually annotated tumor lesions (FDG-PET-CT-Lesions). Cancer Imaging Archive website. https:\/\/www.cancerimagingarchive.net\/collection\/fdg-pet-ct-lesions. Published June 2, 2022. Accessed February 18, 2026.","DOI":"10.1038\/s41597-022-01718-3"},{"key":"2026060105301018000_67.6.1001.25","unstructured":"Bartlett N Wilson W Jung S . Rituximab and combination chemotherapy in treating patients with diffuse large B-cell non-Hodgkins lymphoma (CALGB50303) (version 2). Cancer Imaging Archive website. https:\/\/www.cancerimagingarchive.net\/collection\/calgb50303\/. Updated August 6, 2025. Accessed February 18, 2026."},{"key":"2026060105301018000_67.6.1001.26","unstructured":"iek  Abdulkadir A Lienkamp SS . 3D U-Net: learning dense volumetric segmentation from sparse annotation. In: Ourselin S Joskowicz L Sabuncu M Unal G Wells W , eds. Medical Image Computing and Computer-Assisted InterventionMICCAI 2016. Springer; 2016:424432."},{"key":"2026060105301018000_67.6.1001.27","unstructured":"Cardoso JM Li W Brown R . Monai: an open-source framework for deep learning in healthcare [preprint]. https:\/\/arxiv.org\/pdf\/2211.02701. Accessed February 18, 2026."},{"key":"2026060105301018000_67.6.1001.28","unstructured":"Dozat T. Incorporating Nesterov momentum into Adam. Presented at 4th International Conference on Learning Representations, Workshop Track; May 2016. San Juan, Puerto Rico."},{"key":"2026060105301018000_67.6.1001.29","first-page":"562","volume-title":"Proc Mach Learn Res.","volume":"38","author":"Lee","year":"2015"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:07Z","timestamp":1785269887000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.2967\/jnumed.125.271605"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271605","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}